|This Slide: #78 of 100|
Slide #78. Quest Diagnostics — Solstas Lab Partners
Quest Diagnostics (NYSE:DGX)
Solstas Lab Partners
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the previously announced acquisition of Solstas Lab Partners Group and its subsidiaries (Solstas), a full-service commercial laboratory company based in Greensboro, North Carolina. The combination of Solstas with Quest Diagnostics will give patients and healthcare providers in the Southeastern United States, where Solstas operates in nine states, including the Carolinas, Virginia, Tennessee, Georgia and Alabama, greater access to innovative and cost-effective diagnostic information services.
Quest Diagnostics is a provider of diagnostic information services. Co. is comprised of two businesses: Diagnostic Information Services and Diagnostic Solutions. Co.'s Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers and accountable care organizations. Co.'s Diagnostic Solutions group includes its risk assessment services business, which provides solutions for insurers, and its healthcare information technology businesses, which provides solutions for healthcare providers.
Quest Diagnostics SEC Filing Email Alerts Service
Open the DGX Page at The Online Investor »
Buy (2.70 out of 4)
(ranked lower than approx. 76% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite